Hector Veron
Medical · Riverside, CANPI 1649276346
Payments from drug & device makers
Across 211 payments — averaging $38.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$2K
- Novo Nordisk$685
- Bayer$629
- Lilly USA, LLC$569
- Johnson & Johnson$535
- Boehringer Ingelheim$507
- plus $4K from 27 others
What the payments were for
- Food & beverage$8,048100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 35 | $1,512 |
| Novo Nordisk | 13 | $685 |
| Bayer | 24 | $629 |
| Lilly USA, LLC | 20 | $569 |
| Johnson & Johnson | 11 | $535 |
| Boehringer Ingelheim | 15 | $507 |
| Merck | 17 | $441 |
| Amgen | 3 | $356 |
| Antares Pharma, Inc. | 2 | $322 |
| Phathom Pharmaceuticals, Inc. | 2 | $250 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $241 |
| Pfizer | 10 | $192 |
| Biohaven Pharmaceuticals, Inc. | 6 | $186 |
| GSK | 7 | $181 |
| Abbott | 1 | $159 |
| Exact Sciences | 2 | $143 |
| Axsome Therapeutics, Inc. | 1 | $141 |
| Neurocrine Biosciences, Inc. | 1 | $140 |
| Otsuka America Pharmaceutical, Inc. | 1 | $122 |
| AbbVie | 6 | $117 |
| Novartis | 6 | $102 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $99 |
| Nevro Corp. | 2 | $94 |
| Sanofi-aventis U.S. LLC | 5 | $67 |
| Corcept Therapeutics | 1 | $60 |
| Sanofi Pasteur Inc. | 2 | $39 |
| Amarin Pharma, Inc. | 2 | $33 |
| Eisai Inc. | 2 | $32 |
| Xeris Pharmaceuticals, Inc. | 1 | $24 |
| Ardelyx, Inc. | 1 | $23 |
| Actelion Pharmaceuticals US, Inc. | 1 | $21 |
| Kowa Pharmaceuticals America, Inc. | 1 | $17 |
| Sunovion Pharmaceuticals Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,048 in reported general payments places this provider in the 90th percentile of 2,087 medical providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 22 | $13,897 |
| TrulicityDulaglutide | 13 | $12,182 |
| EliquisApixaban | 12 | $7,323 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 16 | $937 |
| Ketoconazole | 23 | $613 |
| Diclofenac Sodium | 20 | $567 |
| Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide | 18 | $507 |
| Rosuvastatin Calcium | 29 | $487 |
| Tramadol Hcl | 88 | $465 |
| Omeprazole | 66 | $441 |
| Levothyroxine Sodium | 16 | $440 |
| Losartan Potassium | 52 | $432 |
| Metformin Hcl | 58 | $308 |
| Fenofibrate | 12 | $247 |
| Ibuprofen | 24 | $231 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $507 | $13,89722 claims |
| Lilly USA, LLCTrulicity | $569 | $12,18213 claims |
| PfizerEliquis | $192 | $7,32312 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,087 medical providers in California.
Other medical in Riverside
- Nicola LowreyOrange$655K
- Justin LoveLoma Linda$553K
- David DoriguzziLancaster$514K
- Alison GracomIrvine$467K
- Jeffrey BonnaudLos Angeles$314K
- Ana TorresLaguna Beach$229K
- Heather ParlettRedlands$168K
- Deirdre MoxleyFullerton$149K
- Tri leGardena$127K
- Linda RankLadera Ranch$105K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.